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ABSTRACT
Objectives To understand the incidence, causes, 
management and outcomes of intentional (assault) and 
unintentional severe ocular chemical injuries (SOCI) at an 
urban tertiary referral centre in the UK.
Design Retrospective observational study.
Setting A London tertiary referral ophthalmic centre, 
Moorfields Eye Hospital.
Participants All cases of SOCI presenting between 1 
September 2011 and 31 August 2014 were identified. The 
definition of SOCI was grade 3 or 4 on the Hughes- Roper- 
Hall classification system. We identified 25 cases (6 in 
2011–2012, 8 in 2012–2013, 11 in 2013–2014). Median 
age was 31.1 years. 23 cases (92%) were male.
Primary and secondary outcome measures The primary 
outcome was the proportion of cases of SOCI caused by 
assault, per year. Secondary outcome measures included 
the number of cases of SOCI, injury characteristics and 
mechanism, initial and long- term management, visual 
outcome and the need for surgical intervention.
Results Between 2011 and 2012, 3/6 cases were due to 
assault (50%); between 2012 and 2013, 7/8 were due to 
assault (87.5%); and between 2013 and 2014, 6/11 were due 
to assault (54.4%). Assault was responsible for 16/25 (64%) 
cases overall, while 8/25 (32%) cases were work related. 
The causative agent was known to be alkali in 16/25 (64%), 
while 10/25 (40%) did not complete the follow- up. The mean 
number of clock hours of limbal ischaemia was 5.24 (SD 
2.97). 17/25 (68%) were Hughes- Roper- Hall grade 3. Surgical 
intervention occurred in 1/25. The final best- corrected visual 
acuity was 6/12 or worse in 11/25 (44%) and was counting 
fingers or worse in 4/25 (16%).
Conclusions Previous studies found that SOCI had a low 
incidence and that work- related injuries were the most 
common cause. Our study demonstrates an increasing 
incidence of SOCI, which may be accounted for by a rise 
in assault using corrosive substances. A high number of 
patients did not attend regularly for follow- up and visual 
outcomes from these injuries are poor.
INTRODUCTION
Ocular chemical injury is an ophthalmic 
emergency and accounts for 11.5%–22.1% of 
ophthalmic trauma.1 Rapid emergency first- aid 
management with copious irrigation is crucial, 
followed by appropriate acute ophthalmic 
care.2 Fortunately, most injuries are minor and 
unintentional.3 However, severe ocular chem-
ical injuries (SOCI), although infrequent, carry 
a high risk of developing devastating, long- term 
sequelae and sight loss if not managed appro-
priately and promptly.2
There are several factors that influence 
the severity of the injury, including the agent 
itself (acid or alkali), its strength, length of 
contact with the eye, volume and concentra-
tion. SOCI usually results from strong acid 
or alkali agents.4 Alkali injuries are often 
most severe, as the basic charged molecules 
can rapidly cross the corneal epithelium and 
stroma and enter the anterior chamber.2
Several grading systems for ocular chemical 
injuries exist. Hughes noted the relationship 
between initial presenting clinical signs and 
prognosis; this was subsequently amended 
by Ballen and then Roper- Hall.5–7 Although 
more recent systems have been developed, 
the Hughes- Roper- Hall (H- R- H) classifica-
tion system is easy to use and remember, 
maintaining its popularity particularly in the 
ophthalmic emergency department.8 The 
H- R- H system divides the injury into four 
grades. Grade 1 cases are mild with corneal 
epithelial damage only and no limbal isch-
aemia with a clear cornea. Grade 2 demon-
strates a hazy cornea but with iris details still 
Strengths and limitations of this study
 ► This is acase series, spanning 3 years, from a tertia-
ry ophthalmic hospital in London.
 ► The primary outcome was the proportion of cases of 
severe ocular chemical injuries caused by assault, 
per year.
 ► The methodology differs to the previous national 
multicentre prospective (British Ophthalmological 
Surveillance Unit) study conducted between 2005 
and 2006 meaning comparisons should be made 
with caution.
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visible and less than one- third (three clock hours) limbal 
ischaemia. Grade 3 involves between one- third and one- 
half limbal ischaemia (three to six clock hours), hazy 
cornea obscuring iris details and complete epithelial loss. 
Grade 4, the most severe, presents with an opaque cornea 
and greater than one- half limbal ischaemia. H- R- H grades 
3 and 4 are considered SOCI.3 The most recent evolu-
tion of burns classification is the Dua classification which 
includes an assessment of the degree of conjunctival burn 
involvement.9
A surveillance study of SOCI conducted in the UK from 
December 2005 to November 2006 only identified 12 cases 
this year, with a minimum estimated incidence of 0.02 per 
100 000.3 They found that 8/12 (66.7%) patients with 
SOCI were working- age men and half (6/12) occurred 
at work. Assault accounted for 4/12 (33.3%) of injuries.3 
These findings are supported by previous studies investi-
gating mild, as well as SOCI.1 4 10 In one study from the 
USA, similar demographics were reported, although 
assault only accounted for 2 out of 640 cases (0.31%).11 A 
more recent study from the USA investigating the epide-
miological trends of ocular chemical injuries (including 
mild cases) reports a median age of 32, with 56.6% of 
cases being male. Age- specific incidence rates per 100 000 
population were highest among individuals aged between 
20 and 29, with a mean of 17.4/100 000. This study also 
reported a high incidence among infants and children. 
The authors did not report whether injuries were inten-
tional or unintentional.12
SOCI can either be caused by purposeful human action, 
defined as an ‘intentional injury’; chemical assault is an 
example of this. Other injuries are those that are acci-
dental, referred to as unintentional injuries. In the UK, 
particularly in metropolitan centres such as London, there 
has been a rapid rise in chemical assault or so- called ‘acid’ 
attacks.13 This increase has received significant attention 
in the press with a number of high- profile attacks, with the 
incidence increasing by 65% in 2017 alone.14 In London, 
the Metropolitan Police recorded an increase from 162 
cases in 2012 to 454 in 2016; this number is higher than 
all the chemical assaults recorded in India that year.13 
However, a retrospective study from a leading national 
burns centre in London questions whether this increase 
that is being reported in the national press is translating 
into a similar increase in chemical burn presentations.15
The aim of this study was to investigate the number 
and causes of SOCI presentations per year over a 3- year 
period at Moorfields Eye Hospital, a central London 
tertiary referral eye hospital with a 24- hour ophthalmic 
emergency department. In addition, this study aimed to 
describe the demographics, responsible agent, clinical 
presentation and management of SOCI cases.
MATERIALS AND METHODS
This study was a retrospective, observational study of 
patients attending Moorfields Eye Hospital Emergency 
Department with SOCI. Formal patient consent was 
deemed not necessary by the Moorfields ROAD Ethics 
Committee.
SOCIs were defined as either grade 3 or 4 on the 
H- R- H classification system.5 7 The H- R- H classification 
was chosen over the newer Dua classification to follow 
the same inclusion criteria as reported in the British 
Ophthalmological Surveillance Unit (BOSU) study.3 
Furthermore, this classification is what is currently used 
and documented in our emergency department, with the 
treatment protocol dependent on the H- R- H grade.
All electronic records of emergency department 
attendances between 1 September 2011 and 31 August 
2014 were searched for the following coded diagnoses 
‘Chemical Injury or Trauma’ or ‘Chemical Trauma’ who 
were coded as either being admitted or followed up in 
clinic. Patient records were excluded from review if they 
were discharged directly from the department without 
follow- up as these cases would have represented minor 
injuries. All detailed clinical records of these attendances 
were then reviewed by one of two ophthalmologists (EJC 
and JJH) at Moorfields Eye Hospital. Cases meeting the 
SOCI definition above were included in the study. Patients 
with multiple attendances for the same initial event were 
only included once (ie, duplicate records were excluded). 
Patients without H- R- H 3 or 4 were excluded from the 
study; all other records were included. For any missing 
data or outlying values, the records were reviewed again 
by the other ophthalmologist to ensure quality control. 
Data entry and management was conducted within Micro-
soft Excel 2016 (Microsoft, Ridgemont, Virginia, USA), 
while statistical analysis was performed using STATA V.15 
(StataCorp). To calculate p values to determine signifi-
cance when comparing intentional to non- intentional 
injuries, means were compared using the t- test, while cate-
gorical variables were compared using χ2 calculations.
The primary outcome was the proportion of cases of 
SOCI caused by assault, per year. Secondary outcomes 
included the number of cases of SOCI, characteris-
tics and mechanism of the injury, initial and long- term 
management, visual outcome and the need for surgical 
intervention.
Patient and public involvement
Following the publication of our research in an open- 
access, peer reviewed journal, we plan on raising the 
awareness of the risks of chemical injury to the eye and 
measures to prevent this from happening, through public 
awareness campaigns. We would also seek to involve first- 
responders in disseminating the advice on the emergency 
treatment of ocular chemical injuries.
RESULTS
There were 242 attendances coded as either ‘Chemical 
Injury or Trauma’ or ‘Chemical Trauma’ over the study 
period. Complete clinical records were available and 
reviewed for 219 individuals, while the electronic records 
were available for 19 cases. There were three duplicate 
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records and one record was unavailable or missing. The 
retrieval rate for the study was, therefore, 99.6%. Of the 
238 notes reviewed, 25 cases met the inclusion criteria of 
SOCI.
Demographics and mode of injury
The median age at presentation was 31.1 years, (range 
17–74, IQR 27–42). Table 1 describes the patient demo-
graphics and mode of injury, where 23/25 cases (92%) 
were male. Intentional injury caused by assault was 
responsible for 16/25 (64%) cases across the 3 years, with 
the remaining 9/25 (36%) classified as unintentional or 
accidental. Of these, 7/9 (77.8%) of the cases were work 
related. Intentional injuries occurred predominantly 
in public places (including the street, public transport 
and bars/pubs), accounting for 10/16 (62.5%) injuries. 
Intentional injuries at home and at work occurred in 2/16 
(12.5%) and 1/16 (6.25%) of cases, respectively. Injury 
with an alkali substance was reported in 16/25 (64%) and 
unknown in 6/25 (24%).
There were 6 cases of SOCI identified between 2011 
and 2012, of which 3/6 were due to assault (50%); 8 
between 2012 and 2013, 7/8 due to assault (87.5%) and 
11 between 2013 and 2114, 6/11 due to assault (54.4%) 
(figure 1). During the same period, there were 77 652 
encounters in the emergency department in 2011–2012; 
81 899 in 2012–2013 and 85 799 in 2013–2014. This gives 
a presentation rate of SOCI at Moorfields of 0.773 cases 
per 10 000 encounters in 2011–2012; 0.977 cases per 10 
000 encounters in 2012–2013; and 1.28 cases per 10 000 
encounters in 2013–2014. There was a mean year- on- year 
increase of 0.254 cases per 10 000 encounters. There was 
an approximate increase of 65.6% SOCI encounters from 
2011–2012 to 2013–2014.
Clinical presentation
Tables 2 and 3 describe the baseline and follow- up visual 
acuity, H- R- H grade, surgical management and clinical 
outcome for our cohort of patients. At presentation, the 
visual acuity was 6/18 (20/60) or worse in 15/25 (60%) 
of patients, with 3/25 (12%) of patients 6/60 (20/200) 
or worse. The mean number of clock hours of limbal 
ischaemia was 5.24 (SD 2.97). There were 17/25 (68%) 
cases of H- R- H grade 3 and 8/25 (32%) cases of H- R- H 
grade 4. Time to irrigation data were available in 9/25 
(36%) cases: irrigation was performed within 1 hour of 
the index event in only 5/9 (55%) of these cases, while 
the mean time to irrigation was 2.6 hours (range 0.5–15 
hours; SD 4.70).
Management
The initial management instigated in our emergency 
department is described in figure 2. All patients received 
a topical antibiotic and steroid at presentation, 22/25 
(88%) of whom received preservative- free formulations. 
Topical citrate and ascorbate were prescribed in 18/25 
(72%) and 21/25 (84%) of cases, respectively. Oral ascor-
bate and oral doxycycline were administered to 19/25 
(76%) and 15/25 (60%) of patients, respectively. The full 
recommended protocol of preservative free antibiotics 
and steroids; topical citrate and ascorbate; and oral ascor-
bate and doxycycline was followed in 5/25 (20%).
Long term management and outcome
Of the 25 patients with H- R- H grade 3–4 injuries, 10/25 
(40%) failed to comply with standard follow- up regimens 
in our department and were lost to follow- up at various 
Table 1 Patient demographics, mechanism, place of injury 
and chemical agent responsible for the injury
n (%)
Patients 25 100
  Male 23 92
  Female 2 8
Mechanism and place of injury
  Intentional- assault 16 100
  Public- street 8 50
  Public- public transport 1 6.25
  Public- bar/pub 1 6.25
  Work 1 6.25
  Home 2 12.5
  Unknown 3 18.75
  Unintentional 9 100
  Work- cleaning 3 33.3
  Work- building 3 33.3
  Work- vehicle 1 11.1
  Home- cleaning 1 11.1
  Home- other 1 11.1
Chemical agent 25 100
  Acid 1 4
  Alkali 16 64
  Other 2 8
  Unknown 6 24
Figure 1 Patients with assault- related severe ocular 
chemical injury presenting to Moorfields eye Hospital 
between 2011 and 2014 as a proportion of severe ocular 
chemical injury presentations.
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stages of treatment. Of 10, two patients did not attend 
(DNA) for review beyond 1 week and were discharged, 
6/10 DNA reviews beyond 1 month and 2/10 failed to 
attend appointments between 3 and 12 months, despite 
being offered alternative appointments, as per hospital 
policy. The final best- corrected visual acuity (defined here 
as the later of either the last clinic appointment in the 
patient records prior to discharge, or 1 year following the 
index event) was less than 6/12 (20/40) in 11/25 (44%) 
of cases. There were 4/25 (16%) of patient with vision at 
counting fingers or worse at final follow- up (tables 2 and 
3).
Long- term complications included keratoconjuncti-
vitis sicca (6/25), persistent epithelial defects (4/25), 
microbial keratitis (1/25), central pannus (2/25), central 
corneal scarring (8/25), entropion (1/25) and cataract 
(1/25) (table 2). Of note, there were no recorded cases 
of corneal melt, perforation, secondary glaucoma or 
patients requiring eye removal.
Surgical intervention was performed in 1/25 (4%), 
who underwent an amniotic membrane graft, a limbal 
stem cell graft and finally a penetrating keratoplasty. This 
same patient subsequently developed cataract and under-
went uncomplicated phacoemulsification and intraocular 
lens insertion.
Comparison between intentional and unintentional injuries
Table 3 compares the demographics, management and 
outcomes for patients whose injuries were classified as 
either intentional (ie, assault) or unintentional. Inten-
tional injuries occurred solely among men, although this 
was not found to be statistically significant using Fisher’s 
exact test (p=0.12), likely due to the small sample size. 
Unintentional injuries occurred solely at home or at 
Table 2 Best- corrected visual acuity (BCVA) at presentation and at final follow- up, Hughes- Roper- Hall (H- R- H) grade, surgical 




BCVA at final 
follow- up





complications Lost to follow- up?
1 6/9 6/4 3 – No
2 6/18 6/18 3 – KS, CCS No
3 6/24 6/6 3 – No
4 6/6 6/9 3 – CCS No
5 6/12 6/5 3 – DNA at 1/52
6 6/6 6/9 3 – KS No
7 6/24 Unknown 3 – DNA at 1/52
8 6/9 6/12 4 – DNA at 1/12
9 6/9 6/5 3 – No
10 6/24 6/6 4 – KS, CCS, CP No
11 6/9 6/18 4 – DNA at 1/12
12 6/18 6/6 3 – CCS No
13 6/12 6/12 3 – DNA at 1/12
14 6/36 6/9 4 – DNA at 1/12
15 6/24 6/12 4 – DNA at 1/12
16 6/18 6/9 3 – KS, CCS No
17 CF HM 4 – PED No
18 6/18 6/12 3 – No
19 4/60 3/60 3 – DNA at 3/12
20 6/12 HM 3 – KS, PED, CCS DNA at 12/12
21 6/36 HM 4
– KS, PED, MK, CCS, 
CP, Ent No
22 6/36 6/6 3 – DNA at 1/12
23 6/12 6/5 3 – No
24 3/60 6/12 4 – No





AMG, amniotic membrane graft; CCS, central corneal scar; CF, counting fingers; CP, central pannus; DNA, did not attend follow- up; Ent, 
entropion; HM, hand movements; KS, keratoconjunctivitis sicca; LSC, limbal stem cell graft; MK, microbial keratitis; PED, persistent epithelial 
defect; Phaco, phacoemulsification and intra- ocular lens insertion; PK, penetrating keratoplasty.
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work, while the majority of intentional injuries occurred 
in public places (10/16, 62.5%). These differences in 
location between the intentional and unintentional injury 
groups was found to be statistically significant (p=0.003 
and p<0.001 for injury in public and at home or work, 
respectively). Other than these, there was no statistically 
significant difference identified between the intentional 
and unintentional injury groups in terms of presenting 
features, management or outcome.
DISCUSSION
The number of cases of SOCI presenting to Moor-
fields Eye Hospital increased year- on- year between 2011 
and 2014, at a mean increase of 0.254 cases per 10 000 
encounters per year. There was an increase of 65.6% from 
2011/2012 to 2013/2014. The number of cases attribut-
able to assault doubled from 3/6 (50%) to 7/8 (87.5%) 
between 2011/2012 and 2012/2013. In 2013/2014, there 
Table 3 Comparison of select patient demographics, injury mechanism, place of injury, clinical features, management and 
outcome between patients sustaining an intentional injury (ie, assault) and those sustaining an unintentional (accidental) injury
Intentional (assault) n=16 Unintentional n=9 P value
n (%) n (%)
Patients 16 100 9 100
  Male 16 100 7 77.8 0.12
  Female 0 0 2 22.2
Median age (years) 29.7 38.3 0.0897
Mechanism and place of injury
  Injury occurred at home or work 3 18.75 9 100 <0.001*
  Injury occurred in public 10 62.5 0 0 0.003*
  Alkali injury 10 62.5 6 66.7 1
  Acid injury 0 0 1 6.25 0.36
Presenting clinical features
  Presenting BCVA ≤6/12 10 62.5 5 55.6 1
  Presenting BCVA ≤/60 3 18.8 0 0 0.28
  Mean limbal ischaemia 5.75 (SD 2.26) 4.33 (SD 3.94) 0.8293†
  H- R- H grade 3 10 62.5 7 77.8 0.661
  H- R- H grade 4 6 37.5 2 22.2 0.661
Management
  Mean time to irrigation (hours) 5.67 (SD 8.09) 1.17 (SD 0.98) 0.7819†
  Preservative free antibiotics and steroids 12 75 7 77.8 1
  Full treatment protocol 2 12.5 3 33.3 0.312
Outcome
  Patient failed to attend follow- up 6 37.5 4 44.4 1
  Surgical intervention 1 6.25 0 0 1
  Vision ≤6/12 7 43.75 4 44.4 1
  Vision ≥CF 3 18.75 1 11.1 1
*Statistically significant p value. Statistical testing performed: t- test for means if normally distributed; if variances are unequal then adjusted 
using Welch’s formula.
†Fisher’s exact for categorical variables.
BCVA, best corrected visual acuity; H- R- H, Hughes- Roper- Hall Grade.
Figure 2 Initial acute management given in the emergency 
department for patients presenting with severe ocular 
chemical injury (n=25) during the 3- year study period. PF, 
preservative free.
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were 6/11 cases of SOCI caused by assault. Overall across 
the 3 years, assault was responsible for 16/25 (64%) 
presentations.
These results contrast to those of the BOSU study 
from 2005 to 2006.3 The calculated incidence in 2005 
was 0.02 per 100 000, based on the 12 patients reported 
over the course of the year and assuming a UK popula-
tion of 60 million. We report that in 2013/2014, there 
were 11 cases of SOCI seen within one tertiary eye unit in 
Central London. Assuming that Moorfields Eye Hospital 
serves half of the London population for ophthalmic 
services and a population of 8.79 million, we estimate that 
the incidence of SOCI is 0.25 per 100 000 in London. 
This is more than 10 times greater than the 2005–2006 
study. Furthermore, we have found that the proportion 
of injuries due to assault compared with work related is 
64%–28%, respectively; this contrasts to the BOSU results 
of 33% and 50%, respectively. Demographic characteris-
tics between the two studies are similar with SOCI being 
more common in young males, although we found a 
greater proportion of males (92% compared with 75%).
The authors of the BOSU study anticipated a maximum 
of 200–300 cases of SOCI annually in the UK, based on 
two previous studies.3 4 10 If our results were extrapolated 
across the UK with a population of 65.6 million, we would 
expect approximately 164 case of SOCI annually. This 
is closer to Macdonald et al’s anticipated level of cases. 
However, it must be emphasised that the methodology 
differs significantly between the two studies: one is a retro-
spective review of cases at a single tertiary centre while the 
other is a prospective survey conducted across the UK. 
This means that direct comparisons and any conclusions 
should be made with caution. It is also likely that the 
BOSU study may have under- reported the results by up to 
25%.3 With our study being conducted in a tertiary centre, 
our results may overestimate the incidence. Furthermore, 
it is likely that chemical injuries due to assault are higher 
in cities, and possibly in London, compared with the 
rest of the UK. We chose to conduct this present study 
given anecdotal evidence of an increase in SOCI at our 
centre. As opposed to the prospective methodology used 
in BOSU surveillance studies, this enables a ‘snapshot’ 
to gauge trends. We would, therefore, advocate further 
nationwide multicentre prospective studies to evaluate 
the true incidence of SOCI.
A recent study by Bizrah and coworkers from our same 
institution reported 10 patients with SOCI identified over 
3 months in 2016, of which seven (70%) were attribut-
able to assault.16 This suggests that the incidence of SOCI 
continues to increase and that assault- related chemical 
injuries continue to be a problem, with a similar propor-
tion of assault- related injuries as in our cohort of patients.
The reasons behind the rise in ‘acid attacks’ are likely 
multifactorial. In the past, acid attacks were previously 
related to robberies. Now, with tougher legislation 
against carrying knives, corrosive substances were seen 
as a replacement weapon that was harder to detect, with 
no legislation previously in the UK against carrying it. 
However, the Offensive Weapons Act 2019, closes this 
loophole and places restricitons on the sale of corrosive 
substances and makes it an offensive to have a corrosive 
substance in a public place.17 Furthermore, a person 
found guilty is liable for a fine and/or imprisonment 
for up to 12 months. This is in addition to sentencing 
guidelines that classify corrosive substances as ‘highly 
dangerous weapons’, meaning longer custodial sentences 
for those found guilty of using a corrosive substance to 
threaten or assault others.18 Many of these attacks are 
related to gangs, with men being twice as likely as women 
to be the victims.13 It will be interesting to see if these 
legislative changes will translate to a reduced incidence 
of assault- related SOCI and further studies similar to ours 
and that of Bizrah and coworkers are advocated.16
An interesting result from our study is that 40% (10/25) 
of our patients were lost to follow- up as they DNA subse-
quent review appointments. This raises several observa-
tions. First, this may affect the results of our study. For 
example, the final visual acuity may be better than we 
reported if patients with better vision were more likely 
to DNA. Second, although this DNA rate is the same as 
that reported from a recent study relating to SOCI,16 this 
rate is considerably higher than that reported by previous 
studies of general ophthalmic outpatient attendances in 
the UK where the reported rate is 12.5%–12.9%.19 20 This 
is likely to be due to demographics; DNA rates are typically 
higher in young men, those from deprived backgrounds 
and those living in urban areas.21 This patient demo-
graphic is likely over- represented in our study popula-
tion, compared with the general ophthalmic population. 
When comparing intentional to unintentional injuries, 
there was no statistically significant difference between 
the DNA rates between the groups (table 3), indicating 
that assault itself was not a predictor for patients who 
eventually DNA. This finding has important implications 
for outpatient management: patients attending with SOCI 
should receive additional counselling on the importance 
of their follow- up appointments and may benefit from 
additional reminders via telephone calls, emails or text 
messages.
The most important step to treating chemical injury 
and improving the outcome is immediate irrigation—‘di-
lution is the solution’.1 4 22 This is ideally done immedi-
ately at the scene following the exposure, continued by 
the paramedical team in the ambulance on the way to 
hospital and repeated again at presentation until the pH 
has normalised. This should be performed with normal 
saline where available, but if this is not available, clean 
water should be used. In our study, this was performed 
in 5/9 (55%) of patients within 1 hour of the injury, less 
than the 75% reported by Macdonald et al, although it 
is important to consider that we only had data for 36% 
participants.3 There is therefore a need to improve 
people’s awareness of the importance of irrigation. Given 
the shift in the mode of injury from workplace- related 
injury, for which there already exists robust health and 
safety legislation and awareness, to assault related, we 
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suggest raising awareness among people at risk of falling 
victim to ‘acid attacks’ through appropriately targeted 
advertising campaigns.
The aim of early medical management is to reduce 
inflammation and promote corneal re- epithelial-
isation, and prevent acute complications such as 
infection or corneal melt.2 Treatment should avoid 
the use of preserved medications, particularly those 
containing phosphates, as this can precipitate acute 
corneal calcification.23 24 Acute treatment therefore 
involves preservative- free topical steroids and antibi-
otics to reduce inflammation and prevent infection. 
Topical citrate and ascorbate helps to prevent corneal 
melts.25 Oral doxycycline can reduce the inflamma-
tion and the risk of melt.2 Oral ascorbate 1 g daily 
can also prevent collagen lysis, promote healing and 
prevent corneal melts.2 The protocol at Moorfields 
Eye Hospital is that all patients with SOCI receive 
preservative- free steroid and antibiotic, topical ascor-
bate and citrate, oral ascorbate and doxycycline and 
cycloplegia. In our study, while all patients received 
topical steroid and antibiotics, 76% (19/25) received 
preservative- free formulation. This has improved since 
the BOSU study where only half (6/12) of patients 
received preservative- free formulations.3 Topical 
citrate and oral doxycycline were prescribed in 48% 
of patients (12/25), compared with 25% (3/12) of 
patients in the BOSU study.3
Surgical intervention was low in our study, with only 
one patient (1/25, 4%) undergoing surgical treatment. 
This same patient underwent multiple forms of ocular 
surface reconstructive surgery. This low surgical rate of 
intervention seen in our study compares to 50% (6/12) 
of cases in the BOSU study, of which half of these had 
more than one surgical procedure.3 Reasons for this are 
unclear, but it is possible that the high DNA rate may have 
resulted in a falsely low rate of surgical intervention, with 
patients being lost to follow- up before surgical interven-
tion was appropriate.
Final vision was reduced to worse than 6/12 in 44% 
of cases, which is marginally better compared with 50% 
reported by Macdonald et al.3 The rate of very severe visual 
loss (worse than 6/60) was 16% in our study, comparable 
to 16.7% in the BOSU study.3 This suggests that on the 
whole, visual prognosis from SOCI remains poor, with the 
potential for significant morbidity and ocular sequelae as 
a result of the injury.
There are a number of limitations to our study. First, 
as mentioned above, the methodology between our study 
and that of the BOSU study are different, meaning direct 
comparisons should be interpreted with a degree of 
caution. Second, although we report a large case series 
relative to other other studies, the absolute number 
of patients in our study, despite it running for 3 years, 
is only 25, as SOCI is a rare condition. This may make 
statistical analysis challenging, as our sample size may 
be insufficiently powered to detect significance. Third, 
with this study being a retrospective review of case notes, 
the accuracy of the data collected was dependent on the 
record- keeping of the attending clinician. This was mini-
mised by cross- checking the paper clinical records with 
online records that include patient letters and surgical 
interventions, to ensure we did not miss any outcome 
data. We are, therefore, confident that we were able to 
gather all the relevant clinical data for this cohort. Finally, 
the data from this study are from 2011 to 2014 and may 
not necessarily be representative of what is currently 
being seen, particularly given there have been new legis-
lative changes since this data was collected, introduced 
in 2019.17 Until that date, intentional injuries caused by 
corrosive substances had been increasing, suggesting our 
results represent the start of this becoming a significant 
problem in the UK and in particular the London region. 
This is supported by the results form a London- based study 
that reported 70% of SOCI were caused by intentional 
injury in 2016.16 Data on the number of assaults caused by 
corrosive substances since the legislative changes have yet 
to be published; once this is available a subsequent study 
looking at SOCI at our institution would be helpful to see 
the current trend.
This study suggests that there has been a recent 
increase in the incidence of SOCI in a central London 
tertiary eye hospital, with assault now responsible for 
between one half and just under two- thirds of cases. It 
is likely that SOCI is more common than has previously 
been reported, particularly in metropolitan areas. This 
increase may be a result of the recent increase in ‘acid 
attacks’, although further work is necessary to estab-
lish causality. Regardless, there is a need to reverse the 
increase in ‘acid’ attacks through stronger legislation 
to act as a deterrent. There was a lower than expected 
level of initial irrigation and so public awareness of how 
to manage chemical injury could be improved. Similarly, 
first responders and emergency department personnel 
should be reminded of the importance of copious irriga-
tion and onward referral to a specialist ophthalmic unit. 
Ophthalmologists attending these cases should follow 
an evidenced- based protocol and be aware of the risk of 
patients not attending their follow- up appointments and 
plan accordingly. An updated nationwide surveillance 
study is warranted to enable direct comparisons to what 
was seen nearly 15 years ago.
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